Items where Author is "von Moos, R."
 | Up a level |
Conference or Workshop Item
Richtig, E. and Gutzmer, R. and Loquai, C. and Utikal, J. S. and Hoeller, C. and Stadler, R. and Forschner, A. and Hassel, J. C. and Debus, D. and Göppner, D. and Fluck, M. and Haferkamp, S. and Kaatz, M. and Welslau, M. and Dummer, R. and von Moos, R. and Schmidt, A. and Milde, L. and Michielin, O. and Schadendorf, D. (2021) Encorafenib plus Binimetinib in Patients with locally advanced, non-resectable or metastatic BRAF(V600) mutated Melanoma: first Data from the multicenter, multinational, prospective, non-interventional Longitudinal Study BERING(MELANOMA). In: 31. Deutscher Hautkrebskongress (ADO-Jahrestagung), 8.–11. September 2021, hybrid.
Michielin, O. and Richtig, E. and Grimmelmann, I and Loquai, C. and Forschner, A. and Hoeller, C. and Utikal, J. and Gutzmer, R. and Haferkamp, S. and Hassel, J. C. and Debus, D. and Fluck, M. and Goeppner, D. and Kehrer, H. and Dummer, R. and von Moos, R. and Thompson, J. and Milde, L. and Schadendorf, D. (2021) Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAF(V600) mutated melanoma: first data from a multi-centric, multi-national, prospective, longitudinal, non-interventional study - BERINGMELANOMA. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.
Richtig, E. and Debus, D. and Stadler, R. and Hoeller, C. and Utikal, J. S. and Dummer, R. and Haferkamp, S. and von Moos, R. and Michielin, O. and Schadendorf, D. (2020) Encorafenib plus Binimetinib in Patients with locally advanced, inoperable, or metastatic BRAFV600 mutated Melanoma: First Data from the multicenter, multinational, prospective, non-interventional Longitudinal Study BERINGMELANOM. In: 30. Deutscher Hautkrebskongress (ADO‐Jahrestagung), 9. bis 12. September 2020, Virtuell.
